Company intelligence
Berlin Institute of Health
Turning Research into Health
About Berlin Institute of Health
The Berlin Institute of Health (BIH) is a biomedical research institution focusing on translational research and precision medicine. The BIH is dedicated to improving the prediction in progressive diseases and developing advanced therapies for unmet medical needs in order to improve patients’ health and quality of life. The Institute is committed to providing research solutions and innovation enabling value-based, personalized healthcare. The BIH is funded 90% by the Federal Ministry of Education and Research (BMBF) and 10% by the State of Berlin. The two founding institutions, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), are independent, member entities within the BIH.
Verified activity
Signals from Berlin Institute of Health
6 published signals
Research & Knowledge
Berlin Institute of Health published a study in Nature Communications regarding CAR-T cell therapy and immunological composition.
Reported by Berlin Institute of Health
Research & Knowledge
Berlin Institute of Health found that different aspects of a patient’s future clinical trajectory are already encoded at diagnosis — but in different biological layers.
Reported by Simon Haas
Research & Knowledge
Berlin Institute of Health developed a new classification of AML based on leukemic stem and progenitor cell states that extends current classification systems.
Reported by Simon Haas
Research & Knowledge
Berlin Institute of Health assembled a large single-cell multi-omics cohort of 184 patients with acute myeloid leukemia spanning all known subtypes and coupled to deep clinical outcome data.
Reported by Simon Haas
Presence & Recognition
Berlin Institute of Health invited Garima Bhardwaj-Ohlendorf to speak at BioMET 2026 on the translation of biomedical technologies to clinical reality.
Reported by Garima Bhardwaj-Ohlendorf, Ph.D.
People
Berlin Institute of Health appointed Dr. Naveed Ishaque as a new professor of Cancer Bioinformatics at the Charité Berlin in September 2026.
Reported by Berlin Institute of Health